ClinConnect ClinConnect Logo
Search / Trial NCT00682695

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · May 20, 2008

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Stroke Brain Attack Hemorrhagic Stroke Risk Factors

ClinConnect Summary

This clinical trial is focused on understanding the risk factors that can lead to hemorrhagic stroke, which is a type of stroke caused by bleeding in the brain. Researchers want to explore both genetic (things we inherit from our parents) and environmental (influences from our surroundings) factors that might contribute to this condition. The study is currently active, but they are not looking for new participants at this time.

To be eligible for the study, participants must be at least 18 years old and have lived in the area for at least six months. They need to have had a specific type of bleeding in the brain without any other causes, like trauma or tumors. Participants will be asked to provide consent for an interview, some basic health measurements, and a blood sample to help researchers gather important information. This study aims to improve our understanding of hemorrhagic stroke, which could eventually help in preventing and treating this serious condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 or older
  • Resident (6 months or longer) within the recruitment center
  • Fulfillment of the criteria for spontaneous ICH
  • No evidence of trauma, brain tumor/metastases or infectious processes as a cause of the hemorrhage
  • Ability of the patient or legal representative to provide consent for an interview, blood pressure determinations and DNA sampling
  • Exclusion Criteria:
  • N/A

About State University Of New York At Buffalo

The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.

Locations

Boston, Massachusetts, United States

Baltimore, Maryland, United States

Cincinnati, Ohio, United States

Durham, North Carolina, United States

Louisville, Kentucky, United States

New York, New York, United States

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Daniel Woo, MD

Principal Investigator

University of Cincinnati

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials